Search

Learn how new clinical trials at MSK are helping make cancer care at home a reality.

… Monday, June 3, 2024 Robert Daly, MD, MBA, a thoracic oncologist at Memorial Sloan Kettering, presented important new research about delivering high quality cancer care at home during the 2024 ASCO conference, the nation’s premier cancer conference. This research focuses on incorporating telemedicine

VEXAS syndrome is a confounding adult-onset inflammatory disease first described in 2020, which affects 1 in 4,000 men over 50. Now, MSK researchers are shedding new light on its mechanisms and laying the groundwork for potential targeted treatments.

… Monday, November 3, 2025 Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a confounding adult-onset inflammatory disease called VEXAS syndrome — shedding new light on its mechanisms and laying the groundwork for potential targeted

An MSK clinical trial found that participating in integrative therapy classes online could benefit cancer patients in active treatment, not only by reducing fatigue, anxiety, and depression but also lowering hospitalization rates.

… Tuesday, June 17, 2025 As Jan Gura prepared to face the onslaught of standard treatments for stage 2 ovarian cancer, she knew she also wanted integrative therapies that would help her feel better.  “I didn’t know how my body would respond to chemotherapy, but I’ve always been an active person. Being

En un ensayo clínico de MSK se descubrió que participar en clases de terapia integral en línea podría beneficiar a los pacientes que padecen cáncer y reciben tratamiento activo, no solo porque reduce la fatiga, la ansiedad y la depresión, sino también porque disminuye las tasas de hospitalización.

… Tuesday, June 17, 2025 Mientras Jan Gura se preparaba para enfrentarse a la avalancha de tratamientos estándar para el cáncer de ovario en estadio 2, sabía que también quería terapias integrales que la ayudaran a sentirse mejor.  “No sabía cómo respondería mi cuerpo a la quimioterapia, pero siempre he

A gift from the estate of renowned fashion designer Geoffrey Beene will enable MSKCC to launch an ambitious research initiative to be known as the Geoffrey Beene Cancer Research Center.

… Wednesday, September 27, 2006 A gift from the estate of renowned fashion designer Geoffrey Beene will enable Memorial Sloan Kettering Cancer Center (MSKCC) to launch an ambitious research initiative to be known as the Geoffrey Beene Cancer Research Center . It will build on MSKCC’s strong existing scientific

Learn how MSK is Improving patients’ quality of life with less toxic treatments.

… Monday, June 10, 2024 Marc Scarduffa was blindsided when he learned he had stage 3 rectal cancer. Fit and strong as he celebrated his 50th birthday, he had scheduled a colonoscopy simply because he knew he had reached the recommended age to begin screening for colorectal cancer (the recommended age has

A new tool called optogenetics is revealing clues about the function of a promising experimental therapy derived from stem cells.

… Thursday, January 22, 2015 Summary A new tool called optogenetics is revealing clues about the function of a promising experimental therapy derived from stem cells. Stem cell therapy for Parkinson’s disease has shown great promise in animal studies and is moving closer to becoming an option for people

Sloan Kettering Institute’s (SKI) Alexander Gitlin, MD, PhD of Memorial Sloan Kettering Cancer Center (MSK) was recognized as a winner of the National Institutes of Health (NIH) Director’s Early Independence Award.

… Tuesday, October 4, 2022 Today Sloan Kettering Institute’s (SKI) Alexander Gitlin, MD, PhD of Memorial Sloan Kettering Cancer Center (MSK) was recognized as a winner of the National Institutes of Health (NIH) Director’s Early Independence Award. Dr. Gitlin was chosen for his outstanding work and proposal

Learn about some of the latest treatments for thyroid cancer and clinical trials that have been led by researchers from MSK.

… Thursday, July 31, 2025 Thyroid cancer is the most common form of cancer found in the  head and neck area and is diagnosed in more than 44,000 people in the United States every year.  There are many  different types of thyroid cancer. Some, such as early-stage papillary cancers, grow slowly and are easy

In a proof-of-concept study, researchers at MSK and the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from a simple blood test, to predict whether someone’s cancer will respond to immune checkpoint inhibitors, a type of immunotherapy drug that helps immune cells kill cancer cells.

… Monday, June 3, 2024 In a proof-of-concept study, researchers at Memorial Sloan Kettering Cancer Center (MSK) and the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from a simple blood test, to predict whether someone